Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Corticosteroid eyedrops induced blepharoptosis and atrophy of levator muscle

  • 22 Accesses

Abstract

Purpose

The purpose of the study is to analyze the incidence, manifestations, and treatment of blepharoptosis caused by long-term use of corticosteroid eyedrops.

Methods

Retrospective case series include 46 patients with a history of using corticosteroid eyedrops unilaterally for at least 2 months. The palpebral fissure, MRD1, and levator function were evaluated.

Results

Among 46 patients, the differences of mean MRD1 (p < 0.0005), palpebral fissure height (p < 0.0005), and levator function (p = 0.003) between eyes with and without corticosteroid eyedrops application were significant. Ptosis existed in 40 out of 46 eyes with corticosteroid; the differences of the mean MRD1 (p < 0.0005) and palpebral fissure height (p = 0.001) between eyes with and without ptosis were significant. Nine patients underwent levator aponeurosis repair surgeries. Pathological examinations revealed mainly vascular fibers and few muscle fibers, as well as apoptosis of levator palpebrae muscle and Muller muscle.

Conclusion

Blepharoptosis is frequently observed after chronic corticosteroid eyedrops use in Chinese population.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2

References

  1. 1.

    McGhee CN (1992) Pharmacokinetics of ophthalmic corticosteroids. Br J Ophthalmol 76(11):681–684

  2. 2.

    Watson D, Noble MJ, Dutton GN, Midgley JM, Healey TM (1988) Penetration of topically applied dexamethasone alcohol into human aqueous humor. Arch Ophthalmol 106(5):686–687

  3. 3.

    McGhee CN, Noble MJ, Watson DG et al (1989) Penetration of topically applied prednisolone sodium phosphate into human aqueous humour. Eye (Lond) 3(Pt 4):463–467

  4. 4.

    Watson DG, McGhee CN, Midgley JM, Dutton GN, Noble MJ (1990) Penetration of topically applied betamethasone sodium phosphate into human aqueous humour. Eye (Lond) 4(Pt 4):603–606

  5. 5.

    Decramer M (2001) Respiratory muscles in COPD: regulation of trophical status. Verh K Acad Geneeskd Belg 63(6):577–602

  6. 6.

    Lee M-C, Wee G-R, Kim J-H (2005) Apoptosis of skeletal muscle on steroid-induced myopathy in rats. J Nutr 135(7):1806S–1808S

  7. 7.

    Song A, Carter KD, Nerad JA, Boldt C, Folk J (2008) Steroid-induced ptosis: case studies and histopathologic analysis. Eye (Lond) 22(4):491–495

  8. 8.

    Newsome DA, Wong VC, Cameron TP et al (1971) "Steroid-induced" mydriasis and ptosis. Investig Ophthalmol 10(6):424–429

  9. 9.

    Viola F, Morescalchi F, Ratiglia R, Staurenghi G (2007) Ptosis following an intravitreal injection of triamcinolone acetonide. Eye (Lond) 21(3):421–423

  10. 10.

    Morley AM, Tumuluri K, Meligonis G, Collin JR (2009) Myopathic ptosis following posterior sub-Tenon’s triamcinolone acetonide injection. Eye (Lond) 23(3):741–742

  11. 11.

    Ideta S, Noda M, Kawamura R et al (2009) Dehiscence of levator aponeurosis in ptosis after sub-Tenon injection of triamcinolone acetonide. Can J Ophthalmol 44(6):668–672

  12. 12.

    Dal Canto AJ, Downs-Kelly E, Perry JD (2005) Ptosis and orbital fat prolapse after posterior sub-tenon’s capsule triamcinolone injection. Ophthalmology 112(6):1092–1097

  13. 13.

    Zhu Y, Sun C, Zhang X, Shentu X (2017) Ptosis induced by topical steroid eye drops: two cases reports. Medicine (Baltimore) 96(51):e9288

  14. 14.

    McGhee CN, Dean S, Danesh-Meyer H (2002) Locally administered ocular corticosteroids: benefits and risks. Drug Saf 25(1):33–55

  15. 15.

    Loewenstein A, Lipshitz I, Varssano D, Lazar M (1997) Complications of excimer laser photorefractive keratectomy for myopia. J Cataract Refract Surg 23(8):1174–1176

  16. 16.

    Lafranco Dafflon M, Tran VT, Guex-Crosier Y, Herbort CP (1999) Posterior sub-Tenon’s steroid injections for the treatments of posterior ocular inflammation: indications, efficacy and side effects. Graefes Arch Clin Exp Ophthalmol 237(4):289–295

  17. 17.

    Tanner V, Kanski JJ, Frith PA (1998) Posterior sub-Tenon’s triamcinolone injections in the treatment of uveitis. Eye (Lond) 12(Pt 4):679–685

  18. 18.

    Yoshikawa K, Kotake S, Ichiishi A, Sasamoto Y, Kosaka S, Matsuda H (1995) Posterior sub-tenon injections of repository corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol 39(1):71–76

Download references

Funding

This study was funded by the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2018PT32029).

Author information

Correspondence to Xiao-wei Liu.

Ethics declarations

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.

Ethical approval

Procedures performed in this study were in accordance with the ethical standards of the Peking union medical college hospital and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhang, X., Zhang, M., Zhao, D. et al. Corticosteroid eyedrops induced blepharoptosis and atrophy of levator muscle. Graefes Arch Clin Exp Ophthalmol (2020). https://doi.org/10.1007/s00417-020-04622-x

Download citation

Keywords

  • Corticosteroid eyedrops
  • Uveitis
  • Blepharoptosis
  • Atrophy of levator muscle
  • Palpebral fissure
  • Margin reflex distance
  • Levator function